D. Subramanian et al., ULTRAVIOLET-INDUCED DNA-DAMAGE STIMULATES TOPOISOMERASE-I DNA COMPLEX-FORMATION IN-VIVO - POSSIBLE RELATIONSHIP WIT DNA-REPAIR, Cancer research, 58(5), 1998, pp. 976-984
An antibody-based method was used to examine genomic DNA cleavage by e
ndogenous topoisomerases in living cells, The method quantifies cleava
ble (covalent) complex formation in vivo after exposure to topoisomera
se poisons, as reported previously (D. Subramanian et al., Cancer Res.
, 55: 2097-2103, 1995), Unexpectedly, exposing cells tit UVB irradiati
on stimulated endogenous topoisomerase I-DNA covalent complex formatio
n by as much as 8-fold, even in the absence of drugs that stabilize th
e cleavable complex, Covalent complexes are not a result of nonspecifi
c UV protein-DNA cross-linking; rather, they result from the enzymatic
activity of topoisomerase I on genomic DNA, Because the action of top
oisomerase II on genomic DNA was not affected by UVB exposure, the obs
ervation appears to be specific for type I. Topoisomerase I is rapidly
mobilized onto the genome (within 12 min after UVB exposure); however
, topoisomerase I polypeptide levels did not show a corresponding incr
ease, suggesting that preexisting enzyme is being recruited to sites o
f DNA damage, Complexes persist up to 5 h post-UV exposure (concurrent
with the period of active DNA repair), and their formation is indepen
dent of S phase. These findings can be partially explained try the fac
t that in vitro topoisomerase I activity on UV-damaged DNA tends to fa
vor formation of cleavage complexes; thus, a higher yield of covalent
complexes are detected at or near cyclopyrimidine dimer lesions, Becau
se repair-deficient cells are additionally compromised in their abilit
y to recruit topoisomerase I, a direct role for the enzyme in DNA exci
sion repair process in vivo is proposed that may be related to the act
ivity of the xeroderma pigmentosum complementation group D helicase, F
inally, these results collectively demonstrate that topoisomerase I is
a repair-proficient topoisomerase in vivo.